Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $38.6400 (3.43%) ($36.4560 - $39.0400) on Thu. Mar. 17, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.24% (three month average) | RSI | 50 | Latest Price | $38.6400(3.43%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EYES declines -0.4% a day on average for past five trading days. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) CEMB(4%) XLRE(4%) IVE(3%) IVW(3%) IWF(3%) | Factors Impacting EYES price | EYES will decline at least -2.12% in a week (0% probabilities). UNG(-4%) IGOV(-3%) TBT(-2%) IPO(-2%) XLB(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.12% (StdDev 4.24%) | Hourly BBV | 0 () | Intraday Trend | 3.4% | | | |
|
5 Day Moving Average | $39.52(-2.23%) | 10 Day Moving Average | $0(0%) | 20 Day Moving Average | $0(0%) | To recent high | -7.1% | To recent low | 3.4% | Market Cap | $12.342b | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |